Targeted therapy through the use of antibody–drug conjugates holds great promise for the treatment of many malignancies, in particular, breast cancer.
Mateusz Opyrchal, MD, PhD
Advertisement
Articles by Mateusz Opyrchal, MD, PhD
Advertisement
Latest Updated Articles
The Potential of Antibody-Drug Conjugates in the Treatment of Breast CancerPublished: June 23rd 2017 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
